Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermLiab,retainedEarnings,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,dividendsPaid,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,marketState,trailingAnnualDividendYield,epsTrailingTwelveMonths,epsForward,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,exchange,priceHint,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,SRT3.DE,-1340000000.0,34189900,32200000,,174400000,375600000,82000000,166000000,417000000,205100000,205100000,13700000,-41100000,,,,60100000,791100000,586000000,374100000,-30700000,,114300000,82000000,1060500000.0,3557100000.0,1126500000.0,329700000.0,5059200000.0,68400000.0,73200000.0,556500000.0,1406000000.0,1058100000.0,44500000.0,360800000.0,1106900000.0,43000000.0,268500000.0,1058100000.0,1028000000.0,1468700000.0,51500000.0,20600000.0,390700000.0,1823300000.0,623400000.0,391000000.0,,,0,-90400000,84000000,16800000,106400000,157400000,2200000,228900000,53400000,-9500000,-48200000,-54300000,-51400000,-19000000,92800000,-80800000,361800000.0,en-US,US,EQUITY,False,Delayed Quote,1.9594144,571.6 - 584.4,571.6,582.4,582.8,115,68,finmb_881470,XETRA,Sartorius Aktiengesellschaft,EUR,56609,39335,263.19998,0.82352936,319.6 - 584.4,-1.6000366,-0.0027379133,319.6,584.4,0.7,151.9687,7200000,False,False,EUR,REGULAR,0.0012246326,3.835,2.72,16.465,527.83716,54.96283,0.10412838,456.1817,126.618286,0.27756107,38710157312,214.2647,35.396294,15,Europe/Berlin,CEST,SARTORIUS AG VZO O.N.,582.8,1630580268,11.200012,574.8,584.4,571.6,11207,0,GER,2,de_market,0.27,,,584.4,319.6,527.84,456.18,56.61k,39.34k,34.19M,,26.78M,25.61%,30.04%,,,,,,0.71,0.17%,0.70,0.12%,,28.01%,,"Mar 29, 2021",4:1,"Jun 13, 2016","Dec 31, 2020","Mar 31, 2021",10.03%,23.94%,9.79%,28.00%,2.62B,38.25,55.10%,1.21B,779.95M,262.37M,3.84,77.50%,381.4M,5.57,2.18B,145.36,1.33,16.47,627.43M,289.71M,Value,37079,Healthcare,11000,7,6,"Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in GÃ¶ttingen, Germany.",GÃ¶ttingen,49 551 308 0,10,1609372800,1622505600,3,Germany,http://www.sartorius.com,86400,5,Otto-Brenner-Strasse 20,49 551 308 3289,Medical Instruments & Supplies
t-1,SRT3.DE,-1250164000.0,34189900,30525000,,143282000,354593000,77174000,151857000,328102000,178334000,178334000,-32614000,-17786000,,,,34210000,655657000,477323000,327555000,-35052000,,109072000,77174000,916397000.0,3295135000.0,1047619000.0,353456000.0,4697347000.0,68416000.0,92184000.0,532481000.0,1381386000.0,-34249000.0,351461000.0,203435000.0,870943000.0,45022000.0,175438000.0,-34249000.0,803399000.0,1210584000.0,34120000.0,14212000.0,342197000.0,1826337000.0,558556000.0,189811000.0,136891000.0,1013452000.0,0,-359537000,-7152000,-42633000,42226000,-272406000,-1761000,131525000,30196000,-2633000,-48200000,-16455000,-24460000,-35481000,347000,-105454000,339641000.0,en-US,US,EQUITY,False,Delayed Quote,1.9594144,571.6 - 584.4,571.6,582.4,582.8,115,68,finmb_881470,XETRA,Sartorius Aktiengesellschaft,EUR,56609,39335,263.19998,0.82352936,319.6 - 584.4,-1.6000366,-0.0027379133,319.6,584.4,0.7,151.9687,7200000,False,False,EUR,REGULAR,0.0012246326,3.835,2.72,16.465,527.83716,54.96283,0.10412838,456.1817,126.618286,0.27756107,38710157312,214.2647,35.396294,15,Europe/Berlin,CEST,SARTORIUS AG VZO O.N.,582.8,1630580268,11.200012,574.8,584.4,571.6,11207,0,GER,2,de_market,0.27,,,584.4,319.6,527.84,456.18,56.61k,39.34k,34.19M,,26.78M,25.61%,30.04%,,,,,,0.71,0.17%,0.70,0.12%,,28.01%,,"Mar 29, 2021",4:1,"Jun 13, 2016","Dec 31, 2020","Mar 31, 2021",10.03%,23.94%,9.79%,28.00%,2.62B,38.25,55.10%,1.21B,779.95M,262.37M,3.84,77.50%,381.4M,5.57,2.18B,145.36,1.33,16.47,627.43M,289.71M,Value,37079,Healthcare,11000,7,6,"Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in GÃ¶ttingen, Germany.",GÃ¶ttingen,49 551 308 0,10,1609372800,1622505600,3,Germany,http://www.sartorius.com,86400,5,Otto-Brenner-Strasse 20,49 551 308 3289,Medical Instruments & Supplies
t-2,SRT3.DE,-887200000.0,34189900,28000000,,135500000,330200000,68000000,141800000,328900000,143600000,143600000,15500000,-13900000,,,,40700000,623200000,479600000,294300000,-8100000,,94800000,68000000,799900000.0,2940800000.0,882300000.0,262400000.0,4153300000.0,68400000.0,59600000.0,224800000.0,969600000.0,813900000.0,41400000.0,475800000.0,695300000.0,39800000.0,46100000.0,813900000.0,879600000.0,1433200000.0,29600000.0,38400000.0,327700000.0,1956100000.0,531700000.0,265100000.0,,,0,-61500000,217200000,180300000,64200000,285200000,1800000,164600000,47500000,-1700000,-24300000,-40200000,-21900000,-12600000,47000000,-45200000,737900000.0,en-US,US,EQUITY,False,Delayed Quote,1.9594144,571.6 - 584.4,571.6,582.4,582.8,115,68,finmb_881470,XETRA,Sartorius Aktiengesellschaft,EUR,56609,39335,263.19998,0.82352936,319.6 - 584.4,-1.6000366,-0.0027379133,319.6,584.4,0.7,151.9687,7200000,False,False,EUR,REGULAR,0.0012246326,3.835,2.72,16.465,527.83716,54.96283,0.10412838,456.1817,126.618286,0.27756107,38710157312,214.2647,35.396294,15,Europe/Berlin,CEST,SARTORIUS AG VZO O.N.,582.8,1630580268,11.200012,574.8,584.4,571.6,11207,0,GER,2,de_market,0.27,,,584.4,319.6,527.84,456.18,56.61k,39.34k,34.19M,,26.78M,25.61%,30.04%,,,,,,0.71,0.17%,0.70,0.12%,,28.01%,,"Mar 29, 2021",4:1,"Jun 13, 2016","Dec 31, 2020","Mar 31, 2021",10.03%,23.94%,9.79%,28.00%,2.62B,38.25,55.10%,1.21B,779.95M,262.37M,3.84,77.50%,381.4M,5.57,2.18B,145.36,1.33,16.47,627.43M,289.71M,Value,37079,Healthcare,11000,7,6,"Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in GÃ¶ttingen, Germany.",GÃ¶ttingen,49 551 308 0,10,1609372800,1622505600,3,Germany,http://www.sartorius.com,86400,5,Otto-Brenner-Strasse 20,49 551 308 3289,Medical Instruments & Supplies
t-3,SRT3.DE,-980700000.0,34189900,24300000,,78800000,307400000,35300000,139000000,284600000,99400000,99400000,21900000,-20400000,,,,26300000,546900000,447500000,262300000,-20600000,,52500000,35300000,839100000.0,2692900000.0,850100000.0,278400000.0,3850400000.0,68400000.0,55800000.0,225900000.0,991700000.0,26400000.0,30500000.0,190700000.0,796500000.0,29100000.0,170400000.0,26400000.0,866100000.0,1092900000.0,30100000.0,30700000.0,311900000.0,1609800000.0,503800000.0,242000000.0,,755300000.0,0,-803400000,770200000,767600000,55400000,65000000,-600000,101500000,44600000,-2500000,-24300000,-41300000,-30000000,-2600000,37900000,-44800000,296400000.0,en-US,US,EQUITY,False,Delayed Quote,1.9594144,571.6 - 584.4,571.6,582.4,582.8,115,68,finmb_881470,XETRA,Sartorius Aktiengesellschaft,EUR,56609,39335,263.19998,0.82352936,319.6 - 584.4,-1.6000366,-0.0027379133,319.6,584.4,0.7,151.9687,7200000,False,False,EUR,REGULAR,0.0012246326,3.835,2.72,16.465,527.83716,54.96283,0.10412838,456.1817,126.618286,0.27756107,38710157312,214.2647,35.396294,15,Europe/Berlin,CEST,SARTORIUS AG VZO O.N.,582.8,1630580268,11.200012,574.8,584.4,571.6,11207,0,GER,2,de_market,0.27,,,584.4,319.6,527.84,456.18,56.61k,39.34k,34.19M,,26.78M,25.61%,30.04%,,,,,,0.71,0.17%,0.70,0.12%,,28.01%,,"Mar 29, 2021",4:1,"Jun 13, 2016","Dec 31, 2020","Mar 31, 2021",10.03%,23.94%,9.79%,28.00%,2.62B,38.25,55.10%,1.21B,779.95M,262.37M,3.84,77.50%,381.4M,5.57,2.18B,145.36,1.33,16.47,627.43M,289.71M,Value,37079,Healthcare,11000,7,6,"Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in GÃ¶ttingen, Germany.",GÃ¶ttingen,49 551 308 0,10,1609372800,1622505600,3,Germany,http://www.sartorius.com,86400,5,Otto-Brenner-Strasse 20,49 551 308 3289,Medical Instruments & Supplies
